Article Per Year (5 Year)
p-Index From 2021 - 2026
0.562
P-Index
This Author published in this journals
All Journal Cermin Dunia Kedokteran Cermin Dunia Kedokteran
Della Sulamita Mahendro
Medical Department, PT Kalbe Farma Tbk. Jakarta, Indonesia
Health Professions Medicine & Pharmacology Public Health

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
Penggunaan Antivirus untuk COVID-19 Della Sulamita Mahendro
Cermin Dunia Kedokteran Vol 48, No 7 (2021): Infeksi - [Covid - 19]
Publisher : PT. Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v48i7.1459

Abstract

Corona Disease 2019 (COVID-19) ditetapkan sebagai pandemi pada Maret 2020. Hingga saat ini belum ada terapi yang tepat untuk mencegah dan mengobati COVID-19. Beberapa antivirus diteliti sebagai profilaksis dan terapi COVID-19, seperti Hydroxychloroquine, Chloroquine, Lopinavir/Ritonavir, Baloxavir, Umifenovir, Remdesivir, Favipiravir, Oseltamivir, Molnupiravir dan AT527.Corona Disease 2019 (COVID-19) was declared a pandemic in March 2020. Until now, there is no appropriate therapy to prevent and treat COVID-19. Several antivirals are being studied as prophylaxis and treat COVID-19, including : Hydroxychloroquine, Chloroquine, Lopinavir/Ritonavir, Baloxavir, Umifenovir, Remdesivir, Favipiravir, Oseltamivir, Molnupiravir and AT527.
Penggunaan Antivirus untuk COVID-19 Della Sulamita Mahendro
Cermin Dunia Kedokteran Vol 48 No 7 (2021): Infeksi
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v48i7.100

Abstract

Corona Disease 2019 (COVID-19) ditetapkan sebagai pandemi pada Maret 2020. Hingga saat ini belum ada terapi yang tepat untuk mencegah dan mengobati COVID-19. Beberapa antivirus diteliti sebagai profilaksis dan terapi COVID-19, seperti Hydroxychloroquine, Chloroquine, Lopinavir/Ritonavir, Baloxavir, Umifenovir, Remdesivir, Favipiravir, Oseltamivir, Molnupiravir, dan AT527. Corona Disease 2019 (COVID-19) was declared a pandemic in March 2020. Until now, there is no appropriate therapy to prevent and treat COVID-19. Several antivirals are being studied as prophylaxis and treat COVID-19, including: Hydroxychloroquine, Chloroquine, Lopinavir/Ritonavir, Baloxavir, Umifenovir, Remdesivir, Favipiravir, Oseltamivir, Molnupiravir, and AT527.
Penggunaan Antivirus untuk COVID-19 Della Sulamita Mahendro
Cermin Dunia Kedokteran Vol 48 No 7 (2021): Infeksi
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v48i7.100

Abstract

Corona Disease 2019 (COVID-19) ditetapkan sebagai pandemi pada Maret 2020. Hingga saat ini belum ada terapi yang tepat untuk mencegah dan mengobati COVID-19. Beberapa antivirus diteliti sebagai profilaksis dan terapi COVID-19, seperti Hydroxychloroquine, Chloroquine, Lopinavir/Ritonavir, Baloxavir, Umifenovir, Remdesivir, Favipiravir, Oseltamivir, Molnupiravir, dan AT527. Corona Disease 2019 (COVID-19) was declared a pandemic in March 2020. Until now, there is no appropriate therapy to prevent and treat COVID-19. Several antivirals are being studied as prophylaxis and treat COVID-19, including: Hydroxychloroquine, Chloroquine, Lopinavir/Ritonavir, Baloxavir, Umifenovir, Remdesivir, Favipiravir, Oseltamivir, Molnupiravir, and AT527.
Co-Authors